Multiple CNS receptors and enzymes

The term Multiple CNS receptors and enzymes refers to a broad and heterogeneous group of proteins within the central nervous system that serve as the primary sites of action for many psychotropic and neurological medications [Source: NIH]. This category includes various G protein-coupled receptors (GPCRs) such as dopamine, serotonin, and adrenergic receptors, as well as ligand-gated ion channels and enzymes like monoamine oxidase (MAO) or acetylcholinesterase [Source: StatPearls]. These targets play critical roles in regulating neurotransmission, mood, cognition, and motor control, making them central to the treatment of complex disorders like schizophrenia, bipolar disorder, and depression [Source: PubMed]. Many atypical antipsychotics and tricyclic antidepressants are designed to interact with several of these targets simultaneously to achieve therapeutic efficacy through polypharmacology [Source: PubChem]. However, the lack of specificity inherent in targeting multiple CNS components often leads to a wide array of side effects, ranging from sedation and cognitive impairment to metabolic and motor disturbances [Source: FDA]. Understanding the collective interaction of drugs with these multiple sites is essential for optimizing treatment outcomes in neuropsychiatry [Source: Wikipedia].

Other names

Central nervous system targetsCNS polypharmacological targetsMulti-target CNS proteinsCNS receptors and enzymes

Simultaneous modulation of multiple neurotransmitter receptors, ion channels, and metabolic enzymes to achieve a synergistic therapeutic effect in complex neurological and psychiatric conditions [Source: PubMed].